Other researchers have shown that cPLA2 activation promotes neurodegeneration and that the genetic ablation of cPLA2 improves cognitive function and protects against the toxic effects of Aβ oligomers in a mouse model of FAD (Desbène et al., 2012). The gene discussed is PLA2G4A; the disease is familial Alzheimer disease.